Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research

J Clin Hypertens (Greenwich). 2012 Nov;14(11):799-801. doi: 10.1111/jch.12017. Epub 2012 Oct 3.

Abstract

Sympathetic overactivity plays a crucial pathogenetic role in the maintenance and aggravation of arterial hypertension in patients with end-stage renal disease (ESRD). Renal denervation has been shown to be effective and safe in reducing blood pressure (BP) in patients with treatment-resistant hypertension; however, there are only case reports in hypertensive patients with ESRD and data are lacking about possibility of renal denervation in small renal arteries. A woman with uncontrolled treatment-resistant hypertension on chronic hemodialysis underwent bilateral native kidney, catheter-based renal denervation. Both native renal arteries were <4 mm. After 6 months without any change of antihypertensive medication or hemodialysis parameters, the authors observed a remarkable BP reduction of 38/30 mm Hg (from baseline 172/100 mm Hg to 134/70 mm Hg) as evaluated by 24-hour ambulatory BP monitoring. The authors report that renal denervation seems to be effective in controlling hypertension in patients with ESRD, even in cases of small renal arteries.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Catheter Ablation
  • Female
  • Humans
  • Kidney / innervation*
  • Kidney Failure, Chronic / pathology
  • Kidney Failure, Chronic / therapy*
  • Radiography
  • Renal Artery / diagnostic imaging
  • Renal Artery / pathology*
  • Renal Artery / surgery*
  • Renal Dialysis